Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H ( (HK:1541) ) just unveiled an update.
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has established a Nomination Committee to improve its corporate governance structure. This committee is responsible for the selection and appointment of directors and senior management, aiming to optimize board composition and enhance decision-making processes.
More about ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative cancer immunotherapy products. The company aims to enhance cancer treatment through its specialized therapies, targeting a significant market in oncology.
Average Trading Volume: 5,194,140
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.61B
Learn more about 1541 stock on TipRanks’ Stock Analysis page.